NasdaqCM - Nasdaq Real Time Price USD

Fennec Pharmaceuticals Inc. (FENC)

5.95
-0.26
(-4.19%)
As of 12:53:36 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
47,538
47,538
21,252
1,535
0
Cost of Revenue
3,184
3,184
1,259
86
0
Gross Profit
44,354
44,354
19,993
1,449
0
Operating Expense
41,786
41,786
32,764
24,038
17,223
Operating Income
2,568
2,568
-12,771
-22,589
-17,223
Net Non Operating Interest Income Expense
-2,476
-2,476
-3,240
-932
-88
Other Income Expense
-163
-163
-34
-193
-35
Pretax Income
-71
-71
-16,045
-23,714
-17,346
Tax Provision
365
365
0
--
--
Net Income Common Stockholders
-436
-436
-16,045
-23,714
-17,346
Diluted NI Available to Com Stockholders
-436
-436
-16,045
-23,714
-17,346
Basic EPS
-0.04
-0.02
-0.60
-0.90
-0.67
Diluted EPS
-0.04
-0.02
-0.60
-0.90
-0.67
Basic Average Shares
27,210
27,294
26,574
26,275
26,006
Diluted Average Shares
27,693
27,294
26,574
26,275
26,006
Total Operating Income as Reported
2,568
2,568
-12,771
-22,589
-17,223
Total Expenses
44,970
44,970
34,023
24,124
17,223
Net Income from Continuing & Discontinued Operation
-436
-436
-16,045
-23,714
-17,346
Normalized Income
-307.23
-307.23
-16,011
-23,521
-17,311
Interest Income
1,682
1,682
441
195
54
Interest Expense
4,069
4,069
3,394
978
126
Net Interest Income
-2,476
-2,476
-3,240
-932
-88
EBIT
3,998
3,998
-12,651
-22,736
-17,220
EBITDA
4,798
4,798
-12,651
-22,736
-17,220
Reconciled Cost of Revenue
3,184
3,184
1,259
86
0
Reconciled Depreciation
800
800
0
149
16
Net Income from Continuing Operation Net Minority Interest
-436
-436
-16,045
-23,714
-17,346
Total Unusual Items Excluding Goodwill
-163
-163
-34
-193
-35
Total Unusual Items
-163
-163
-34
-193
-35
Normalized EBITDA
4,961
4,961
-12,617
-22,543
-17,185
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-34.23
-34.23
0
0
0
12/31/2021 - 9/15/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACOG Alpha Cognition Inc. Common Stock
7.28
-2.54%
 
EPRX Eupraxia Pharmaceuticals Inc.
3.8000
0.00%
 
ONCO.ST Oncopeptides AB (publ)
1.8240
-2.88%
 
SNPX Synaptogenix, Inc.
2.4162
-2.96%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
VRCA Verrica Pharmaceuticals Inc.
0.4513
+8.69%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.2500
+0.81%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
XRTX XORTX Therapeutics Inc.
1.0162
-0.37%
 
ATXI Avenue Therapeutics, Inc.
0.2201
0.00%